Nanobiotix is trading 7.4% down now at $35.36 after no clear company-specific announcement was identified for September 9, 2026.

  • Broader sentiment is risk-off, with major U.S. indices lower and oil-related geopolitical concerns weighing on equities.
  • The market decline is modest and does not clearly explain Nanobiotix’s larger move; pre-market trading appears thin, with external trackers reporting limited activity and conflicting prices.